| Serial Number | 90835339 |
| Word Mark | DULAVIGO |
| Filing Date | Monday, July 19, 2021 |
| Status | 731 - SECOND EXTENSION - GRANTED |
| Status Date | Tuesday, January 2, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, November 22, 2022 |
| Goods and Services | Pharmaceutical preparations for human use for the treatment and prevention of obesity, incontinence, cardiovascular diseases, central nervous system diseases and disorders, metabolic disorders, stroke, cancer, inflammation and inflammatory diseases, respiratory and infectious diseases, auto-immune diseases, solid organ transplant rejection, beta thalassemia and myelodysplastic syndromes, myeloproliferative diseases, myelofibrosis, leukemia, lymphoma, multiple myeloma, autoinflammatory disease, blood disease, tumors, multiple sclerosis, ulcerative colitis, arthritis, and musculoskeletal and skin diseases; Pharmaceutical preparations for human use, namely, antibiotics, anti-fungals, anti-virals, immunosuppressants, pharmaceutical antibodies, immunotherapies for the treatment of cancer, cytokine inhibitory drugs; Pharmaceutical preparations for human use that modulate the immune system; Pharmaceutical preparations for human use for immunotherapy, namely, T Cell therapy; Pharmaceutical preparations for human use, namely, stem cells for medical or clinical use; Pharmaceutical preparations for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, antivirals for treatment or prevention of covid-19, coronavirus disease, and respiratory diseases and disorders; Pharmaceutical preparations for human use, namely, monoclonal antibodies |
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Tuesday, September 21, 2021 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Princeton, NJ 08543 |
| Party Name | Bristol-Myers Squibb Company |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | New York, NY 10016 |
| Event Date | Event Description |
| Thursday, January 4, 2024 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Tuesday, January 2, 2024 | SOU EXTENSION 2 GRANTED |
| Tuesday, January 2, 2024 | SOU EXTENSION 2 FILED |
| Tuesday, January 2, 2024 | SOU TEAS EXTENSION RECEIVED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF CORRESPONDENCE RECEIVED |
| Wednesday, August 2, 2023 | APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED |
| Wednesday, August 2, 2023 | TEAS CHANGE OF OWNER ADDRESS RECEIVED |
| Wednesday, July 12, 2023 | NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED |
| Monday, July 10, 2023 | SOU EXTENSION 1 GRANTED |
| Monday, July 10, 2023 | SOU EXTENSION 1 FILED |
| Monday, July 10, 2023 | SOU TEAS EXTENSION RECEIVED |
| Tuesday, January 17, 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, November 22, 2022 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| Tuesday, November 22, 2022 | PUBLISHED FOR OPPOSITION |
| Wednesday, November 2, 2022 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, October 13, 2022 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Thursday, October 13, 2022 | EXAMINER'S AMENDMENT ENTERED |
| Thursday, October 13, 2022 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| Thursday, October 13, 2022 | EXAMINERS AMENDMENT E-MAILED |
| Thursday, October 13, 2022 | EXAMINERS AMENDMENT -WRITTEN |
| Wednesday, September 14, 2022 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, September 13, 2022 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Tuesday, September 13, 2022 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Wednesday, March 16, 2022 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Wednesday, March 16, 2022 | NON-FINAL ACTION E-MAILED |
| Wednesday, March 16, 2022 | NON-FINAL ACTION WRITTEN |
| Wednesday, March 9, 2022 | ASSIGNED TO EXAMINER |
| Tuesday, September 21, 2021 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Thursday, July 22, 2021 | NEW APPLICATION ENTERED |